Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an options trading signal again: unusual options activity screeners and strategies. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Curis Inc (CRIS)

Curis Inc (CRIS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 69,889
  • Shares Outstanding, K 96,398
  • Annual Sales, $ 10,650 K
  • Annual Income, $ -45,440 K
  • 60-Month Beta 2.89
  • Price/Sales 6.42
  • Price/Cash Flow N/A
  • Price/Book 1.21
Trade CRIS with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.64
  • Most Recent Earnings -0.14 on 11/09/22
  • Next Earnings Date 02/23/23
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 335.27% ( +67.81%)
  • Historical Volatility 76.72%
  • IV Percentile 69%
  • IV Rank 22.29%
  • IV High 1,326.95% on 11/10/22
  • IV Low 50.87% on 04/21/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 23
  • Volume Avg (30-Day) 57
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 21,960
  • Open Int (30-Day) 28,959

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.14
  • Number of Estimates 2
  • High Estimate -0.13
  • Low Estimate -0.14
  • Prior Year -0.15
  • Growth Rate Est. (year over year) +6.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5500 +41.42%
on 01/03/23
0.7990 -2.65%
on 01/13/23
+0.2278 (+41.42%)
since 12/30/22
3-Month
0.4700 +65.49%
on 12/27/22
0.9296 -16.33%
on 11/15/22
-0.0834 (-9.68%)
since 11/02/22
52-Week
0.4700 +65.49%
on 12/27/22
3.7550 -79.29%
on 02/10/22
-2.2322 (-74.16%)
since 02/02/22

Most Recent Stories

More News
Curis Announces Additional Encouraging Clinical Data from TakeAim Leukemia Study of emavusertib (CA-4948) in Monotherapy R/R AML and hrMDS

/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...

CRIS : 0.7840 (+8.14%)
Curis to Host Webcast to Discuss Updated Emavusertib Clinical Data in Leukemia

/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...

CRIS : 0.7840 (+8.14%)
Curis (CRIS) Reports Q3 Loss, Misses Revenue Estimates

Curis (CRIS) delivered earnings and revenue surprises of 17.65% and 6.77%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

CRIS : 0.7840 (+8.14%)
BFRI : 0.8781 (+1.99%)
Curis: Q3 Earnings Snapshot

Curis: Q3 Earnings Snapshot

CRIS : 0.7840 (+8.14%)
Curis Provides Third Quarter 2022 Business Update

/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...

CRIS : 0.7840 (+8.14%)
Agenus (AGEN) Reports Q3 Loss, Tops Revenue Estimates

Agenus (AGEN) delivered earnings and revenue surprises of -5.56% and 14.69%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

AGEN : 2.69 (+3.86%)
CRIS : 0.7840 (+8.14%)
Curis Announces Three Presentations at SITC 2022

/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...

CRIS : 0.7840 (+8.14%)
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...

CRIS : 0.7840 (+8.14%)
Curis Announces Date for the 1st Symposium on IRAK4 in Cancer

/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...

CRIS : 0.7840 (+8.14%)
Curis Announces Date for the 2nd Annual VISTA Symposium

/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...

CRIS : 0.7840 (+8.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Curis, Inc. is a therapeutic drug development company focusing on cancer, neurological and dermatological disease indications, with technologies that utilize regulatory pathways that control repair and regeneration. Curis' product development involves the use of small molecules or proteins to modulate...

See More

Key Turning Points

3rd Resistance Point 0.8047
2nd Resistance Point 0.7823
1st Resistance Point 0.7537
Last Price 0.7840
1st Support Level 0.7027
2nd Support Level 0.6803
3rd Support Level 0.6517

See More

52-Week High 3.7550
Fibonacci 61.8% 2.5001
Fibonacci 50% 2.1125
Fibonacci 38.2% 1.7249
Last Price 0.7840
52-Week Low 0.4700

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar